Physician

Sirisha Gudlawar

According to 2025 Medicare claims, Sirisha Gudlawar (NPI: 1225590268) practices internal medicine in the Kenosha, WI market, with the plurality of this provider's patient population coming from Kenosha, WI. This provider's primary affiliated billing organization is FROEDTERT SOUTH, INC. (NPI: 1558305284; TIN: 390816845) and primary practice location at 53158-1984.

Gudlawar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 201 traditional Medicare patients, billed 1,110 HCPCS/CPT codes, and received $75,088 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 844 prescription claims across 171 beneficiaries totaling $158,919 in drug costs, led by Xphozah (Tenapanor Hcl). Open Payments data shows 1 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,037 to $158,919. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$38K$75K2024 Medicare payment: $75,088 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20242011,110$75,088

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$79K$159K2019 Drug cost: $1,037 (USD; Tot_Drug_Cst)2020 Drug cost: $4,652 (USD; Tot_Drug_Cst)2021 Drug cost: $1,115 (USD; Tot_Drug_Cst)2022 Drug cost: $2,055 (USD; Tot_Drug_Cst)2023 Drug cost: $1,657 (USD; Tot_Drug_Cst)2024 Drug cost: $158,919 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192549$1,037
20203271$4,652
20211331$1,115
20222447$2,055
2023N/R21$1,657
2024171844$158,919

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3553$129
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3546$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more85128$94
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes43159$58
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6881$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XphozahTenapanor Hcl15450$45,394
VeltassaPatiromer Calcium Sorbitex27968$33,425
JardianceEmpagliflozin221,606$27,038
FarxigaDapagliflozin Propanediol171,106$21,843
Calcium AcetateCalcium Acetate261,518$2,352

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$29Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sirisha Gudlawar?

Tedicare shows public-source Medicare data for Sirisha Gudlawar (NPI 1225590268), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sirisha Gudlawar have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sirisha Gudlawar?

Sirisha Gudlawar is linked to FROEDTERT SOUTH, INC. (billing NPI 1558305284) in the available physician profile data.

Does Sirisha Gudlawar have Open Payments data?

Sirisha Gudlawar has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.